Here are the top health news for the day:
WHO says probing four Indian cough syrups after 66 children die in Gambia
After the World Health Organization (WHO) issued an alert on four India-made cough and cold syrups used for pediatric groups, the Central Drugs Standard Control Organization (CDSCO) has taken up an urgent investigation in this regard.
"Urgent investigation in the matter has been already taken up by CDSCO with the State Regulatory Authorities immediately after receiving communication from WHO based on the available information. While all required steps will be taken in the matter, as a robust National Regulatory Authority, WHO has been requested to share at the earliest with CDSCO the report on the establishment of causal relation to death with the medical products in question, photographs of Labels/ products etc. which is awaited," Sources told ANI.
For more details, check out the link given below:
Indian Cough Syrups Linked To 66 Children Deaths In Gambia, WHO Alerts, CDSCO Begins Investigation
Drug safety alert: IPC flags adverse reactions linked to rheumatoid arthritis drug piroxicam
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of September ,has revealed that Piroxicam, a non-steroidal anti-inflammatory agent (NSAID) which is used to treat the symptoms of osteoarthritis and rheumatoid arthritis, is linked with Adverse Drug Reactions (ADRs) named Fixed Drug Eruption.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.